Saturday 17 October 2026
Export QGEN’s income statement to Excel — free account
QIAGEN N.V.
QGEN Healthcare Diagnostics & Research
QIAGEN N.V.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 5.65% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 7.94%, free cash flow grew 30.5% and total debt rose 13.8%, each against the same quarter a year earlier.
46.13
0.04
−0.09%
Follow QGEN
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
22.30 | 117.80 | 27.50 | 25.09 | 23.25 | 31.93 | 0.00 | 38.84 | 170.50 | 79.51 |
Piotroski F-Score |
8 | 5 | 4 | 5 | 7 | 7 | 3 | 7 | 6 | 4 |
P/S ratio |
4.67 | 5.01 | 4.97 | 5.06 | 5.20 | 5.97 | 4.64 | 4.81 | 4.66 | 4.76 |
Altman Z-Score |
3.81 | 4.00 | 3.84 | 3.67 | 3.53 | 3.25 | 2.31 | 2.39 | 2.61 | 3.23 |
Altman Z″-Score (non-manufacturers) |
5.06 | 4.34 | 4.64 | 4.46 | 3.34 | 3.31 | 2.46 | 3.33 | 3.80 | 3.83 |
P/FCF ratio |
21.84 | 19.74 | 32.91 | 19.14 | 27.09 | 72.68 | 126.64 | 34.58 | 40.71 | 25.70 |
Beneish M-Score |
(2.60) | (2.89) | (2.30) | (2.81) | (2.60) | (2.52) | (2.66) | (2.62) | (2.67) | (2.79) |
P/Operating CF |
51.92 | 51.76 | 64.51 | 87.12 | 59.03 | 41.38 | 64.76 | 65.32 | 86.93 | 63.66 |
Dividend Safety Score |
66 | — | — | — | — | — | — | — | — | — |
P/B ratio |
2.59 | 2.78 | 2.56 | 3.12 | 3.78 | 3.99 | 2.79 | 2.74 | 2.60 | 2.44 |
Price to Tangible BV |
14.14 | 11.83 | 12.13 | 19.03 | 98.99 | 0.00 | 0.00 | 140.46 | 229.79 | 51.18 |
EV/Sales |
5.18 | 5.13 | 5.20 | 5.26 | 5.59 | 6.61 | 5.19 | 5.26 | 5.18 | 5.16 |
EV/EBITDA |
16.33 | 31.78 | 15.83 | 14.57 | 14.35 | 19.52 | 32.21 | 15.53 | 18.62 | 20.77 |
EV/Operating CF |
16.54 | 15.07 | 22.24 | 15.76 | 19.71 | 27.02 | 23.96 | 21.96 | 25.62 | 20.21 |
EV/FCF |
24.20 | 20.21 | 34.44 | 19.92 | 29.12 | 80.54 | 141.64 | 37.83 | 45.23 | 27.86 |
Quick Ratio |
2.93 | 1.44 | 1.33 | 1.79 | 0.94 | 1.92 | 1.36 | 1.94 | 4.29 | 2.70 |
Current Ratio |
3.90 | 1.88 | 1.99 | 2.46 | 1.39 | 2.84 | 1.65 | 2.22 | 5.07 | 3.36 |
Net Debt/EBITDA |
0.84 | 0.75 | 0.70 | 0.57 | 1.00 | 1.91 | 3.41 | 1.33 | 1.88 | 1.62 |
Debt/Assets |
26.34% | 24.46% | 24.69% | 29.60% | 31.59% | 32.76% | 32.59% | 37.82% | 35.09% | 24.89% |
Debt/Equity |
0.44 | 0.39 | 0.40 | 0.54 | 0.63 | 0.69 | 0.67 | 0.83 | 0.70 | 0.41 |
Asset Turnover |
0.35 | 0.34 | 0.32 | 0.34 | 0.37 | 0.34 | 0.28 | 0.28 | 0.30 | 0.32 |
Operating CF/Net income |
1.54 | 8.06 | 1.35 | 1.69 | 1.25 | 1.27 | (7.98) | 1.89 | 7.10 | 4.25 |
Capex/Depreciation |
(1.05) | (0.77) | (0.69) | (0.62) | (0.84) | (1.23) | (1.01) | (0.62) | (0.52) | (0.40) |
Interest Coverage |
14.01 | 2.23 | 7.68 | 9.11 | 11.57 | 5.42 | (0.35) | 3.96 | 3.09 | 2.53 |
| 11.57% | 2.27% | 9.38% | 12.90% | 17.39% | 13.47% | (1.60%) | 7.36% | 1.57% | 3.11% | |
| 7.10% | 1.42% | 5.50% | 6.81% | 8.53% | 6.47% | (0.75%) | 3.53% | 0.86% | 1.89% | |
ROIC |
6.72% | 1.60% | 6.01% | 8.50% | 9.91% | 6.03% | (0.48%) | 5.03% | 2.92% | 1.96% |
Return on Tangible Assets |
17.65% | 5.00% | 18.62% | 20.33% | 41.66% | 22.29% | (3.86%) | 11.23% | 2.22% | 6.90% |
Average Days of Receivables |
70.31 | 64.45 | 70.92 | 55.18 | 58.70 | 74.26 | 102.16 | 93.94 | 94.92 | 82.40 |
Research and Development Expense of Revenue |
8.97% | 9.78% | 10.10% | 8.87% | 8.44% | 7.97% | 10.31% | 10.78% | 10.87% | 11.20% |
Selling, General and Administrative Expense of Revenue |
27.93% | 28.53% | 29.47% | 28.20% | 25.96% | 28.09% | 33.03% | 33.08% | 40.61% | 41.62% |
Intangible Assets out of Total Assets |
0.49 | 0.48 | 0.49 | 0.46 | 0.48 | 0.53 | 0.53 | 0.45 | 0.50 | 0.58 |
Share Based Compensation of Revenue |
2.41% | 2.21% | 2.40% | 2.31% | 1.71% | 2.19% | 4.32% | 2.67% | 2.43% | 2.11% |
Graham Net Nets |
(0.05) | (0.02) | (0.02) | (0.04) | (0.08) | (0.13) | (0.16) | (0.13) | (0.13) | (0.10) |
Graham Number |
28.09 | 11.67 | 25.45 | 27.61 | 29.01 | 22.92 | 0.00 | 16.35 | 7.29 | 10.30 |
Earnings Yield |
4.48% | 0.85% | 3.64% | 3.99% | 4.30% | 3.13% | (0.64%) | 2.57% | 0.59% | 1.26% |
Free Cash Flow Yield |
4.58% | 5.07% | 3.04% | 5.23% | 3.69% | 1.38% | 0.79% | 2.89% | 2.46% | 3.89% |
Revenue per Share |
9.62 | 8.89 | 9.07 | 10.19 | 11.02 | 9.14 | 7.51 | 7.40 | 6.94 | 6.36 |
Operating CF per Share |
3.01 | 3.03 | 2.12 | 3.40 | 3.13 | 2.24 | 1.63 | 1.77 | 1.40 | 1.62 |
Capex per Share |
(0.95) | (0.77) | (0.75) | (0.71) | (1.01) | (1.49) | (1.35) | (0.74) | (0.61) | (0.45) |
Free Cash Flow per Share |
2.06 | 2.26 | 1.37 | 2.69 | 2.12 | 0.75 | 0.28 | 1.03 | 0.79 | 1.18 |
Cash per Share |
5.06 | 5.18 | 4.88 | 6.75 | 5.22 | 3.50 | 4.27 | 7.37 | 5.01 | 2.53 |
Shareholders Equity per Share |
17.39 | 16.02 | 17.57 | 16.49 | 15.16 | 13.67 | 12.49 | 12.98 | 12.44 | 12.39 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
17.39 | 16.02 | 17.57 | 16.49 | 15.16 | 13.67 | 12.49 | 12.98 | 12.44 | 12.39 |
Free Cash Flow |
447.20 | 502.31 | 296.65 | 565.93 | 432.47 | 153.57 | 55.96 | 208.73 | 162.42 | 247.74 |
Working Capital |
1,482.94 | 917.82 | 1,068.27 | 1,419.43 | 592.13 | 1,052.23 | 618.90 | 1,182.87 | 1,323.18 | 729.14 |
Capital Expenditures |
(207.13) | (171.24) | (162.80) | (149.34) | (206.53) | (304.24) | (274.88) | (150.76) | (124.36) | (93.86) |
Net Current Asset Value |
(508.00) | (162.43) | (159.87) | (427.17) | (940.80) | (1,447.37) | (1,128.78) | (958.30) | (849.55) | (663.53) |
EV/EBIT |
23.23 | 103.90 | 24.92 | 21.21 | 19.98 | 32.01 | 0.00 | 29.62 | 47.88 | 69.85 |
Capex to Sales |
0.10 | 0.09 | 0.08 | 0.07 | 0.09 | 0.16 | 0.18 | 0.10 | 0.09 | 0.07 |
Price to Operating Income |
20.97 | 101.45 | 23.82 | 20.38 | 18.59 | 28.88 | 0.00 | 27.08 | 43.10 | 64.43 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.21 | 0.29 | 0.31 | 0.37 | 0.39 | 0.44 | 0.60 | 0.47 | 0.49 | 0.53 |
Cash ROIC |
6.85% | 8.22% | 4.65% | 8.39% | 7.09% | 2.83% | 1.10% | 3.31% | 3.05% | 5.88% |
Accounts Receivable Turnover |
5.56 | 5.41 | 5.57 | 6.24 | 6.06 | 4.63 | 3.75 | 3.98 | 4.23 | 4.44 |
Accounts Payable Turnover |
10.14 | 12.08 | 8.00 | 7.57 | 7.30 | 6.28 | 6.76 | 7.79 | 8.97 | 9.53 |
Inventory Turnover |
2.72 | 2.98 | 1.93 | 2.21 | 2.59 | 2.76 | 3.12 | 3.14 | 3.38 | 3.61 |
Average Days of Payables |
33.55 | 30.07 | 41.98 | 47.61 | 46.14 | 67.63 | 59.37 | 50.58 | 43.66 | 37.89 |
Days of Inventory on Hand |
139.39 | 100.83 | 198.75 | 172.61 | 149.28 | 166.68 | 119.55 | 118.71 | 114.98 | 101.03 |
Average Receivables |
375.94 | 365.58 | 352.81 | 342.94 | 371.33 | 403.88 | 406.89 | 377.60 | 335.34 | 301.42 |
Average Payables |
77.96 | 83.71 | 91.44 | 99.98 | 109.69 | 101.46 | 77.09 | 64.31 | 55.21 | 51.76 |
Average Inventory |
290.57 | 338.82 | 378.17 | 342.74 | 309.35 | 230.94 | 166.81 | 159.42 | 146.24 | 136.57 |
Average Assets |
5,985.43 | 5,902.41 | 6,201.46 | 6,217.34 | 6,008.29 | 5,552.62 | 5,491.97 | 5,393.42 | 4,673.36 | 4,243.66 |
Average Common Equity |
3,672.75 | 3,687.55 | 3,637.19 | 3,281.58 | 2,947.19 | 2,667.22 | 2,585.78 | 2,587.98 | 2,574.05 | 2,587.58 |
Columns are period end dates